InDex Pharmaceuticals Holding AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was SEK 37.94 million compared to SEK 3.45 million a year ago. Basic loss per share from continuing operations was SEK 0.07 compared to SEK 0.01 a year ago.
For the nine months, sales was SEK 97.51 million. Revenue was SEK 108.03 million compared to SEK 66.43 million a year ago. Net income was SEK 10.25 million compared to net loss of SEK 44.03 million a year ago. Basic earnings per share from continuing operations was SEK 0.02 compared to basic loss per share from continuing operations of SEK 0.08 a year ago.